India, March 27 -- The Ozempic craze is not yet over. Originally developed for type 2 diabetes, the drug that took celebrities and social media by storm for its weight loss effects now has a new competitor in the Indian market. Enter Eli Lilly, an American pharmaceutical company, which launched Mounjaro (tirzepatide) in India last week on March 20....